Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Clinical trials of new antipsychotics: a critical appraisal
Autore:
Barbui, C; Garattini, S;
Indirizzi:
Marioboratingnst Pharmacol Res, Lab Epidemiol & Social Psychiat, WHO, Colla Mario Negri Inst Pharmacol Res Milan Italy I-20157 Psychiat, WHO, Colla
Titolo Testata:
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
fascicolo: 2, volume: 14, anno: 1999,
pagine: 133 - 137
SICI:
0268-1315(199903)14:2<133:CTONAA>2.0.ZU;2-L
Fonte:
ISI
Lingua:
ENG
Soggetto:
DOUBLE-BLIND TRIAL; SCHIZOPHRENIC-PATIENTS; NEGATIVE SYMPTOMS; OLANZAPINE TRIAL; HALOPERIDOL; ZOTEPINE; CLOZAPINE; PLACEBO;
Keywords:
antipsychotic drugs; randomized controlled trials; schizophrenia; trial methodology;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
27
Recensione:
Indirizzi per estratti:
Indirizzo: Barbui, C Marioboratingnstlyharmacol Res, Lab Epidemiol & Social Psychiat,WHO, Colla Mario Negri Inst Pharmacol Res Via Eritrea 62 Milan Italy I-20157
Citazione:
C. Barbui e S. Garattini, "Clinical trials of new antipsychotics: a critical appraisal", INT CLIN PS, 14(2), 1999, pp. 133-137

Abstract

In recent years the efficacy of new antipsychotics has been investigated through a number of randomized controlled trials. This paper considers some methodological flaws that affect these studies and proposes possible solutions. The final goal is the implementation of a new generation of trials with the aim of demonstrating superiority of effect of the new antipsychotic over the reference one. Int Clin Psychopharmacol 14:133-137 (C) 1999 Lippincott Williams & Wilkins.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 17/01/20 alle ore 20:11:38